SeaCrest Wealth Management, LLC

Position in NVS — Novartis AG

CIK 1728121 PURCHASE, NY

Position in NVS

as of Jun 30, 2026 · filed Jul 9, 2026 Compact

Position Value

$212,669

-$32,618 QoQ

Shares Held

1,357

-33.1% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.04%

of 13F equity value

Holder Rank

#1,290

of 1,603 holders

Holding Since

Dec 2020

11 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

SeaCrest Wealth Management, LLC holds $36,014,537 across 11 Drug Manufacturers - General names. NVS ranks #11 (0.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	13,553	$16,255,876
2	JNJ	Johnson & Johnson	20,122	$5,110,384
3	AMGN	Amgen Inc	13,712	$4,965,389
4	MRK	Merck & Co., Inc.	21,502	$2,763,007
5	ABBV	AbbVie Inc.	8,765	$2,205,624
6	PFE	Pfizer Inc	84,062	$2,024,212
7	GILD	Gilead Sciences, Inc.	6,283	$793,794
8	BMY	Bristol Myers Squibb Co	13,634	$785,591

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$212,669	1,357	-33.1%	Shares	Sole	2026-07-09
2025-06-30	$245,287	2,027	-9.2%	Shares	Sole	2025-07-11
2025-03-31	$248,934	2,233	-1.7%	Shares	Sole	2025-04-11
2024-12-31	$220,991	2,271	+6.2%	Shares	Sole	2025-01-14
2023-12-31	$215,974	2,139	-23.4%	Shares	Sole	2024-01-18
2023-09-30	$284,393	2,792	+12.7%	Shares	Sole	2023-10-12
2023-06-30	$250,054	2,478	-8.7%	Shares	Sole	2023-07-14
2023-03-31	$249,596	2,713	+14.0%	Shares	Sole	2023-05-12
2022-12-31	$215,822	2,379	+7.5%	Shares	Sole	2023-02-14
2022-06-30	$186,980	2,212	+1.7%	Shares	Sole	2022-08-09
2020-12-31	$205,290	2,174	—	Shares	Sole	2021-02-09
No filing history on record for this holder in this stock.